Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRNA | KYMR | QGEN | ||
| Company | Verona Pharma Plc ADR | Kymera Therapeutics Inc | Qiagen N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 106.85 | 106.63 | 43.12 | ||
| High | 106.93 | 109.05 | 44.41 | ||
| Low | 106.81 | 106.04 | 43.12 | ||
| Last | 106.91 | 108.10 | 43.76 | ||
| Change | +0.12 | +0.58 | +1.46 | ||
| Percent Change | +0.11% | +0.54% | +3.45% | ||
| Volume | 1,871,900 | 228,132 | 1,969,293 | ||
| 20-Day Average Volume | 1,504,320 | 529,833 | 2,394,040 | ||
| Previous | 106.79 | 107.52 | 42.30 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 106.48 | 108.75 | 41.62 | ||
| 20-Day Raw Stochastic | 98.26% | 38.01% | 90.10% | ||
| 20-Day Relative Strength | 70.52 | 53.12 | 65.46 | ||
| Weighted Alpha | +201.62 | +111.59 | -10.30 | ||
| Today's Opinion | 100% Buy | 80% Buy | 40% Buy | ||
| Yesterday's Opinion | 100% Buy | 80% Buy | 24% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.28% since 09/29/25 | +6.91% since 08/03/26 | +3.73% since 08/03/26 | ||
| Low | 106.61 on 09/30/25 | 100.53 on 08/04/26 | 40.87 on 08/06/26 | ||
| High | 106.93 on 10/06/25 | 109.05 on 08/10/26 | 44.41 on 08/10/26 | ||
| 1-Month | |||||
| %Chg | +0.56% since 09/05/25 | -10.15% since 07/10/26 | +5.78% since 07/10/26 | ||
| Low | 105.78 on 09/19/25 | 99.52 on 08/03/26 | 39.36 on 07/21/26 | ||
| High | 106.93 on 10/06/25 | 119.83 on 07/20/26 | 44.41 on 08/10/26 | ||
| 3-Month | |||||
| %Chg | +16.80% since 07/03/25 | +24.58% since 05/08/26 | +32.90% since 05/08/26 | ||
| Low | 86.63 on 07/08/25 | 69.48 on 06/03/26 | 32.53 on 05/13/26 | ||
| High | 106.93 on 10/06/25 | 130.05 on 06/25/26 | 44.41 on 08/10/26 | ||
| 6-Month | |||||
| %Chg | +98.35% since 04/04/25 | +34.91% since 02/10/26 | -14.04% since 02/10/26 | ||
| Low | 47.20 on 04/07/25 | 69.48 on 06/03/26 | 32.53 on 05/13/26 | ||
| High | 106.93 on 10/06/25 | 130.05 on 06/25/26 | 52.20 on 02/13/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,748,446 | 8,940,396 | 8,716,972 | ||
| Shares Outstanding, K | 81,830 | 83,151 | 206,075 | ||
| Annual Sales, $M | 42,280,000 | 39,210,000 | 2,090,000,000 | ||
| Annual Net Income, $M | -173,420,000 | -311,350,000 | 424,880,000 | ||
| Last Qtr Sales, $M | 103,140,000 | 34,370,000 | 492,320,000 | ||
| Last Qtr Income, $M | 11,920,000 | -69,230,000 | 68,040,000 | ||
| 60-Month Beta | 0.05 | 1.95 | 0.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.13 on 08/06/25 | -0.62 on 08/05/26 | 0.62 on 08/05/26 | ||
| Latest Earnings Date | 11/03/25 | 11/03/26 | 11/03/26 | ||
| Most Recent Dividend | N/A | N/A | 0.350 on 07/07/26 | ||
| Next Ex-Dividend Date | N/A | N/A | 07/07/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 17.23 | ||